The Scientist

» drug development and microbiology

Most Recent

image: 23andMe Enters Drug Development

23andMe Enters Drug Development

By | March 12, 2015

The personal genomics firm announces plans to make medicines.

4 Comments

image: Sewage Bacteria Linked to Obesity

Sewage Bacteria Linked to Obesity

By | March 10, 2015

Microbes identified in a city’s sewage treatment plants correlate with the population’s obesity rate, a study shows.

1 Comment

image: AbbVie Wins Bidding War for Cancer Drugmaker

AbbVie Wins Bidding War for Cancer Drugmaker

By | March 5, 2015

The pharmaceutical firm beat out a host of potential suitors, Johnson & Johnson among them, to strike a $21 billion deal with Pharmacyclics.

0 Comments

image: Nanobombs Terminate Foodborne Microbes

Nanobombs Terminate Foodborne Microbes

By | March 5, 2015

Researchers engineer water nanostructures to wipe out pathogens that can spoil food and pose health risks.

2 Comments

image: Tough-to-Clean Equipment a Bigger Problem

Tough-to-Clean Equipment a Bigger Problem

By | March 2, 2015

The number of deaths attributable to certain medical probes may go beyond a recent outbreak in Los Angeles.

2 Comments

image: Of Cells and Limits

Of Cells and Limits

By | March 1, 2015

Leonard Hayflick has been unafraid to speak his mind, whether it is to upend a well-entrenched dogma or to challenge the federal government. At 86, he’s nowhere near retirement.

3 Comments

image: Medical Equipment May Spread Superbug

Medical Equipment May Spread Superbug

By | February 20, 2015

Drug-resistant bacteria have spread in a Los Angeles hospital, perhaps from contaminated endoscopes.

1 Comment

image: Clinic Trial Problems Kept Mum

Clinic Trial Problems Kept Mum

By | February 11, 2015

Despite documented dysfunction in a number of studies, rarely do those problems get a mention in the resulting publications, according to a new study.

0 Comments

image: Subway Microbiome

Subway Microbiome

By | February 9, 2015

Researchers document the bacterial life living among New York City’s transit stations.

0 Comments

image: Lazarus Drugs

Lazarus Drugs

By | February 1, 2015

While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.  

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech